Financial Performance

Thirty years ago, a US human rights report on a mining giant disappeared. A new investigation asks why, exposing a pattern of secrecy and human cost.

As employees flock to prediction markets, a new insider trading risk emerges. A new tech alliance aims to give firms the visibility they've been missing.

As giants rule the obesity market, small-cap MetaVia pitches a novel dual-agonist and a first-in-class MASH drug. Can its science win the day?

Glass House Brands follows a new playbook, splitting its business to chase a NYSE listing. Is this the key that unlocks institutional capital for the entire sector?

A new mid-year outlook reveals how geopolitical turmoil, the AI boom, and a renewed focus on sovereignty are reshaping investment strategies for a volatile H2 2026.

Verastem Oncology's combo therapy posts impressive early data in a notoriously deadly cancer, revealing a shrewd strategy for tackling drug resistance.

XCharge's new C7 charger boasts record power, but its real test lies in winning public trust. A deep dive into the tech, strategy, and partnerships redefining speed.

With a promising drug and a fortified war chest, Trevi Therapeutics’ upcoming conference tour is a calculated move to conquer a vast, unmet medical need.

With a new $400M debt facility, Dyne Therapeutics is accelerating two promising drugs for DMD and DM1, showcasing the power of strategic, non-dilutive financing.

A new low-risk trial program for hybrid vehicles reveals China's pragmatic strategy to win over markets where pure EVs can't yet compete.

Gene therapy firm uniQure plans a 2026 FDA submission for AMT-130, a potential first disease-modifying treatment for Huntington's, on an accelerated track.

New research reveals that custom 3D braces can actively correct spinal curves, not just prevent them from worsening. This paradigm shift in non-surgical care offers new hope.

Albertsons Media Collective and P&G are ditching ads for scripted dramas, using shopper data to create entertainment. Is this the future of retail media?

A new platform promises to streamline rental applications for the gig economy. But can it build real trust between landlords and tenants in an era of fraud?

As gold and silver prices soar, Starcore International Mines upgrades to the OTCQX market. A strategic bid for US investors, but what's beneath the surface?

As AI becomes the new front door for travel, a new partnership gives hotels the tools to fight for their own narrative against the dominance of OTAs.

High-grade results, including 170.9 g/t gold, are more than just numbers; they signal a strategic push to restart a historic mine and boost a region.

SolarWinds appoints ex-USAF intelligence officer Justin Henkel as its new CISO, a strategic move to fortify its defenses and lead in the age of AI.

As the world scrambles for lithium, Canadian developer Lithium Ionic heads to a key conference, showcasing its advanced Brazilian project and its role in a new supply chain.

At BIO 2026, Israeli biotech Can-Fite seeks crucial partnerships for its late-stage cancer and inflammation drugs, built on a unique, safety-focused platform.